Application of Proteomics and Machine Learning Methods to Study the Pathogenesis of Diabetic Nephropathy and Screen Urinary Biomarkers.

Journal: Journal of proteome research
PMID:

Abstract

Diabetic nephropathy (DN) has become the main cause of end-stage renal disease worldwide, causing significant health problems. Early diagnosis of the disease is quite inadequate. To screen urine biomarkers of DN and explore its potential mechanism, this study collected urine from 87 patients with type 2 diabetes mellitus (which will be classified into normal albuminuria, microalbuminuria, and macroalbuminuria groups) and 38 healthy subjects. Twelve individuals from each group were then randomly selected as the screening cohort for proteomics analysis and the rest as the validation cohort. The results showed that humoral immune response, complement activation, complement and coagulation cascades, renin-angiotensin system, and cell adhesion molecules were closely related to the progression of DN. Five overlapping proteins (KLK1, CSPG4, PLAU, SERPINA3, and ALB) were identified as potential biomarkers by machine learning methods. Among them, KLK1 and CSPG4 were positively correlated with the urinary albumin to creatinine ratio (UACR), and SERPINA3 was negatively correlated with the UACR, which were validated by enzyme-linked immunosorbent assay (ELISA). This study provides new insights into disease mechanisms and biomarkers for early diagnosis of DN.

Authors

  • Xi Yan
    College of Life Science and Oceanography, Shenzhen University, Shenzhen 518060, China.
  • Xinglai Zhang
    College of Life Science and Oceanography, Shenzhen University, Shenzhen 518060, China.
  • Haiying Li
    State Key Laboratory of Chemical Engineering and Department of Chemistry , East China University of Science and Technology , Shanghai , 200237 , China . Email: hlliu@ecust.edu.cn.
  • Yongdong Zou
    Center for Instrumental Analysis, Shenzhen University, Shenzhen 518071, China.
  • Wei Lu
    Department of Pharmacy, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Man Zhan
    Department of Endocrinology, Guiyang First People's Hospital, Guiyang, Guizhou 550002, China.
  • Zhiyuan Liang
    College of Life Science and Oceanography, Shenzhen University, Shenzhen 518060, China.
  • Hongbin Zhuang
    College of Life Science and Oceanography, Shenzhen University, Shenzhen 518060, China.
  • Xiaoqian Ran
    College of Life Science and Oceanography, Shenzhen University, Shenzhen 518060, China.
  • Guanwei Ma
    College of Life Science and Oceanography, Shenzhen University, Shenzhen 518060, China.
  • Xixiao Lin
    College of Life Science and Oceanography, Shenzhen University, Shenzhen 518060, China.
  • Hongbo Yang
    Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.
  • Yuhan Huang
    College of Life Science and Oceanography, Shenzhen University, Shenzhen 518060, China.
  • Hanghang Wang
    College of Life Science and Oceanography, Shenzhen University, Shenzhen 518060, China.
  • Liming Shen
    College of Life Science and Oceanography, Shenzhen University, Shenzhen 518060, China.